PRMT5 and glioblastoma: Whilst reduction in PTEN activity through promoter suppression by PRMT5 can lead to an alternative mechanism of upregulation of this axis in glioblastoma, the same is not observed in PDAC, lung cancer and gastric cancer [42,90,122,123].